Gupta, Shantanu 
; Silveira, Daner Acunha ; Mombach, Jose Carlos M. ; Hashimoto, Ronaldo Fumio
Fonte: Journal of The Royal Society Interface. Unidade: IME
Assuntos: NEOPLASIAS PULMONARES, MEDICAMENTO, SIMULAÇÃO, GEOMETRIA E MODELAGEM COMPUTACIONAL, ESTRATÉGIAS TERAPÊUTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUPTA, Shantanu et al. Targeting NSCLC drug resistance: systems biology insights into the MALAT1/miR-145-5p axis and Wip1 in regulating ferroptosis and apoptosis. Journal of The Royal Society Interface, v. 22, n. 226, p. 1-11, 2025Tradução . . Disponível em: https://doi.org/10.1098/rsif.2024.0852. Acesso em: 08 out. 2025.APA
Gupta, S., Silveira, D. A., Mombach, J. C. M., & Hashimoto, R. F. (2025). Targeting NSCLC drug resistance: systems biology insights into the MALAT1/miR-145-5p axis and Wip1 in regulating ferroptosis and apoptosis. Journal of The Royal Society Interface, 22( 226), 1-11. doi:10.1098/rsif.2024.0852NLM
Gupta S, Silveira DA, Mombach JCM, Hashimoto RF. Targeting NSCLC drug resistance: systems biology insights into the MALAT1/miR-145-5p axis and Wip1 in regulating ferroptosis and apoptosis [Internet]. Journal of The Royal Society Interface. 2025 ; 22( 226): 1-11.[citado 2025 out. 08 ] Available from: https://doi.org/10.1098/rsif.2024.0852Vancouver
Gupta S, Silveira DA, Mombach JCM, Hashimoto RF. Targeting NSCLC drug resistance: systems biology insights into the MALAT1/miR-145-5p axis and Wip1 in regulating ferroptosis and apoptosis [Internet]. Journal of The Royal Society Interface. 2025 ; 22( 226): 1-11.[citado 2025 out. 08 ] Available from: https://doi.org/10.1098/rsif.2024.0852
